ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Revenue

ACADIA Pharmaceuticals had revenue of $250.40M in the quarter ending September 30, 2024, with 18.28% growth. This brings the company's revenue in the last twelve months to $929.24M, up 47.06% year-over-year. In the year 2023, ACADIA Pharmaceuticals had annual revenue of $726.44M with 40.45% growth.

• Revenue (ttm): $929.24M
• Revenue Growth: +47.06%
• P/S Ratio: 2.89
• Revenue / Employee: $1,553,906
• Employees: 598
• Market Cap: 2.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	726.44M	209.20M	40.45%
Dec 31, 2022	517.24M	33.09M	6.83%
Dec 31, 2021	484.15M	42.39M	9.60%
Dec 31, 2020	441.76M	102.68M	30.28%
Dec 31, 2019	339.08M	115.27M	51.50%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.